Open AccessRisk Factors for Cytomegalovirus Viremia following Liver Transplantation With a Seropositive Donor and Seronegative Recipient Receiving Antiviral Therapy
Author(s) -
Nina Singh,
Drew J. Winston,
Raymund R. Razonable,
G. Marshall Lyon,
Fernanda P. Silveira,
Marilyn M. Wagener,
Ajit P. Limaye
Publication year - 2020
Publication title -
the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiaa470
Subject(s) - viremia , medicine , valganciclovir , immunology , odds ratio , cytomegalovirus , transplantation , viral load , human cytomegalovirus , confidence interval , population , risk factor , gastroenterology , viral disease , ganciclovir , herpesviridae , antibody , virus , environmental health
The risk factors for development of viremia in high-risk donor cytomegalovirus (CMV)-seropositive and recipient CMV-seronegative (D+R-) transplant recipients are incompletely defined.